click below
click below
Normal Size Small Size show me how
Diseases Seen in Y4
| Nephrotic Syndrome | Definition: Clinical syndrome - >3g Proteinuria/day due to glomerular disorder + peripheral odema + hypoalbuminaemia + hyperlipidaemia | Epidemiology | ||||
| Biological behaviour/ clinical manifestations | Investigations | |||||
| Aetiology / Pathophysiology Primary/idiopathic NS (INS) : - Minimal Change Disease (MCD) - Focal Segmental Gloerulosclerosis (FSGS) - Membranoproliferative Glomerulonephritis (MPGN) - Membranous Glomerulonephritis (MGN) Secondary NS: Infection, medicat | ||||||
| Definition: Clinical syndrome - >3.5g Proteinuria/day due to glomerular disorder + peripheral odema + hypoalbuminaemia (< 2.5g/dL) + hyperlipidaemia | Epidemiology INS peaks in childhood (2.5 y/o - MCD, 6y/o -FSGS). M:F = 3:2. | Aetiology / Pathophysiology Primary/idiopathic NS (INS) : GLOMERULNEPHRITIS - Minimal Change Disease (MCD) - Focal Segmental Gloerulosclerosis (FSGS) - Membranoproliferative Glomerulonephritis (MPGN) - Membranous Glomerulonephritis (MGN) Secondary NS: | Biological behaviour [symptoms] / clinical manifestations I.e. signs - Proteinuria [foamy urine] - Progressive lower extremity oedema [pitting odema, swelling of ankles, legs, hands, abdo, weight gain from fluid retention] - [Fatigue, weakness, loss of a | Investigations - Urine tests (urine dipstick for Proteinuria, hematuria is a sign of GN), (MSU + culture to rule out infection) (24h urine - level of of urine protein secretion) (urine protein electrophoresis) (first morning void -prot:creat) - Blood test | Management - manage symptoms + treat underlying disease - Treat Proteinuria (ACEi/ARB for HT), spironolactone, increase dietary protein intake - Treat oedema (limit Na intake, restrict fluid intake, diuretics - furosemide) - Hypercoagulability (prophylact | |
| NephrItic Syndrome | Definition | Epidemiology | Aetiology/Pathophysiology | Biological behaviour [symptoms] / clinical manifestations (signs) | Investigations | Management |